1. Home
  2. XPER vs ELDN Comparison

XPER vs ELDN Comparison

Compare XPER & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xperi Inc.

XPER

Xperi Inc.

N/A

Current Price

$5.42

Market Cap

271.2M

Sector

Technology

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$1.90

Market Cap

219.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPER
ELDN
Founded
1990
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
271.2M
219.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
XPER
ELDN
Price
$5.42
$1.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
★ $11.40
$9.00
AVG Volume (30 Days)
394.7K
★ 889.5K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 30.67
EPS
★ N/A
N/A
Revenue
★ $448,105,000.00
N/A
Revenue This Year
$1.90
N/A
Revenue Next Year
$4.49
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.91
$1.35
52 Week High
$8.75
$4.49

Technical Indicators

Market Signals
Indicator
XPER
ELDN
Relative Strength Index (RSI) 44.52 34.76
Support Level $4.99 N/A
Resistance Level $5.92 $3.14
Average True Range (ATR) 0.26 0.23
MACD -0.00 -0.08
Stochastic Oscillator 27.86 2.37

Price Performance

Historical Comparison
XPER
ELDN

About XPER Xperi Inc.

Xperi Inc is a media and entertainment technology company. Its technologies are integrated into consumer devices, connected cars, and a variety of media platforms globally, enabling audiences to connect with entertainment content in a more intelligent, immersive, and personal way. As its audiences engage with content on the platform, the company operates a cross-screen advertising solution that enables brands to reach millions of engaged consumers across rapidly expanding digital entertainment ecosystem. It operates in one reportable business segment and group its revenue into four categories: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Geographically it operates in U.S. and Canada, Asia Pacific, Europe, Middle East and Africa, and Other countries.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: